全文获取类型
收费全文 | 114639篇 |
免费 | 31961篇 |
国内免费 | 1079篇 |
专业分类
耳鼻咽喉 | 2585篇 |
儿科学 | 3091篇 |
妇产科学 | 2800篇 |
基础医学 | 4601篇 |
口腔科学 | 5375篇 |
临床医学 | 27701篇 |
内科学 | 28119篇 |
皮肤病学 | 3577篇 |
神经病学 | 13893篇 |
特种医学 | 4287篇 |
外国民族医学 | 3篇 |
外科学 | 20590篇 |
综合类 | 621篇 |
现状与发展 | 40篇 |
一般理论 | 43篇 |
预防医学 | 15344篇 |
眼科学 | 2381篇 |
药学 | 2341篇 |
中国医学 | 35篇 |
肿瘤学 | 10252篇 |
出版年
2024年 | 547篇 |
2023年 | 5062篇 |
2022年 | 1166篇 |
2021年 | 2942篇 |
2020年 | 5416篇 |
2019年 | 2287篇 |
2018年 | 7213篇 |
2017年 | 7538篇 |
2016年 | 8082篇 |
2015年 | 8242篇 |
2014年 | 10746篇 |
2013年 | 12654篇 |
2012年 | 4501篇 |
2011年 | 4295篇 |
2010年 | 7277篇 |
2009年 | 9511篇 |
2008年 | 4240篇 |
2007年 | 3272篇 |
2006年 | 4466篇 |
2005年 | 2986篇 |
2004年 | 2297篇 |
2003年 | 1925篇 |
2002年 | 1784篇 |
2001年 | 2385篇 |
2000年 | 1740篇 |
1999年 | 2219篇 |
1998年 | 2317篇 |
1997年 | 2082篇 |
1996年 | 2153篇 |
1995年 | 1902篇 |
1994年 | 1244篇 |
1993年 | 1066篇 |
1992年 | 1166篇 |
1991年 | 1028篇 |
1990年 | 859篇 |
1989年 | 886篇 |
1988年 | 825篇 |
1987年 | 692篇 |
1986年 | 642篇 |
1985年 | 590篇 |
1984年 | 506篇 |
1983年 | 510篇 |
1982年 | 395篇 |
1981年 | 346篇 |
1980年 | 249篇 |
1979年 | 306篇 |
1978年 | 300篇 |
1977年 | 258篇 |
1973年 | 244篇 |
1972年 | 257篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Role of Isoflavones in the Hypocholesterolemic Effect of Soy 总被引:2,自引:0,他引:2
Isabelle Demonty PhD Benoît Lamarche PhD Peter J. H. Jones PhD 《Nutrition reviews》2003,61(6):189-203
Epidemiologic data suggest an inverse relationship between the consumption of soy isoflavones and cardiovascular disease risk. The aims of this review are to determine if isoflavones play a role in the hypocholesterolemic effect of soy and whether the studies realized with that scope were adequately designed. In humans, most studies have been performed in postmenopausal women. The results are inconsistent, however; some studies show a decrease in total cholesterol and low-density lipoprotein concentrations, and an increase in high-density lipoprotein levels, and other investigations fail to show any beneficial effect of soy isoflavones on lipid profiles. In most studies, beneficial effects could not be attributed with certainty to soy isoflavones. If these components have any health-protecting effect in humans, it is small in comparison with the effect of soy protein itself. There are currently not enough data to recommend the consumption of isoflavone supplements to lower plasma cholesterol levels. 相似文献
992.
993.
Desmond FS Cormack RMN RGN MPhil DipEd PhD DipN Honorary Reader in Health Nursing William Reynolds RMN RNT RGN MPhil Senior Tutor 《Journal of advanced nursing》1992,17(12):1472-1478
Arguably, nursing, like all health care disciplines, is an applied science. Essentially, this refers to the application of theory in order to understand and respond to the health problems of clients. These theories may be drawn (borrowed) from any applied science, or generated inductively from clinical nursing practice. Alternatively, nurses may attempt to apply deductive theory (global theoretical frameworks) known as nursing models. In this paper, all theoretical approaches, irrespective of origin, are referred to as models used by nurses. Thirteen criteria by which clinicians, and others, can evaluate the clinical and practical utility of models used by nurses which are expressed in the form of questions are identified and discussed. The criteria are an extension, both in detail and in number, of those developed by Reynolds and Cormack and subsequently applied by those writers to the Johnson Behavioural System Model of Nursing. The value, or otherwise, of individual models, or of models in general, will not be discussed in this paper. However, the authors propose that if the evaluation criteria described here are applied to existing models, serious deficits will be identified in relation to their clinical and practical utility. 相似文献
994.
Editorial 总被引:1,自引:0,他引:1
995.
996.
Michael J. Schull MD MSc Therese A. Stukel PhD Marian J. Vermeulen MHSc Astrid Guttmann MDLM MSc Merrick Zwarenstein MD PhD 《Academic emergency medicine》2006,13(11):1228-1231
Background Current influenza pandemic models predict a surge in influenza‐related hospitalizations in affected jurisdictions. One proposed strategy to increase hospital surge capacity is to restrict elective hospitalizations, yet the degree to which this measure would meet the anticipated is unknown. Objectives To compare the reduction in hospitalizations resulting from widespread nonurgent hospital admission restrictions during the Toronto severe acute respiratory syndrome (SARS) outbreak with the expected increase in admissions resulting from an influenza pandemic in Toronto. Methods The authors compared the expected influenza‐related hospitalizations in the first eight weeks of a mild, moderate, or severe pandemic with the actual reduction in the number of hospital admissions in Toronto, Ontario, during the first eight weeks of the SARS‐related restrictions. Results Influenza modeling for Toronto predicts that there will be 4,819, 8,032, or 11,245 influenza‐related admissions in the first eight weeks of a mild, moderate, or severe pandemic, respectively. In the first eight weeks of SARS‐related hospital admission restrictions, there were 3,654 fewer hospitalizations than expected in Toronto, representing a modest 12% decrease in the overall admission rate (a reduction of 1.40 admissions per 1,000 population). Therefore, influenza‐related admissions could exceed the reduction in admissions resulting from restricted hospital utilization by 1,165 to 7,591 patient admissions, depending on pandemic severity, which corresponds to an excess of 0.44 to 2.91 influenza‐related admissions per 1,000 population per eight weeks, and an increase of 4% to 25% in the overall number of admissions, when compared with nonpandemic conditions. Conclusions Pandemic modeling for Toronto suggests that influenza‐related admissions would exceed the reduction in hospitalizations seen during SARS‐related nonurgent hospital admission restrictions, even in a mild pandemic. Sufficient surge capacity in a pandemic will likely require the implementation of other measures, including possibly stricter implementation of hospital utilization restrictions. 相似文献
997.
Trial of Low-Dose 5-Fluorouracil/Cisplatin Therapy for Advanced Extramammary Paget's Disease 总被引:2,自引:0,他引:2
Kiyonori Kariya MD Takuo Tsuji MD PhD Robert A. Schwartz MD MPH 《Dermatologic surgery》2004,30(S2):341-344
Background. An effective chemotherapy for advanced extramammary Paget's disease has not yet been established. Recently, a low dose 5-fluorouracil/cisplatin (FP) regimen has been reported to be effective for adenocarcinoma, including gastric and colon carcinoma. However, this chemotherapeutic option has not been evaluated as to its effectiveness for extramammary Paget's disease.
Objective. We evaluated chemotherapy in a patient with advanced extramammary Paget's disease of the male genitalia unassociated with an underlying malignancy.
Methods. In order to treat a patient with extramammary Paget's disease who had multiple metastases, 500 mg/day of 5-fluorouracil (7 days per week) and 5 mg/day of cisplatin (5 days per week) were administrated intravenously for 24 hours and 1 hour, respectively. This protocol was continued for 6 weeks.
Results. A partial response was observed in both primary disease and metastatic disease. The primary tumor resolved almost entirely, leaving only a scar. Computed tomography scan revealed liver metastases that appeared to change into necrotic tissue; the metastases in lymph nodes and adrenal glands were markedly decreased and hardly detectable. In addition, the carcinoembryonic antigen level, a useful tumor marker for extramammary Paget's disease, decreased remarkably. It is suggested that this patient's survival period could have been prolonged. Serious side effects were not observed during this treatment.
Conclusion. In one patient with extramammary Paget's disease and multiple metastases, low-dose FP therapy appeared to be beneficial. This regimen may be effective for extramammary Paget's disease with systemic nodular metastasis as an adjuvant therapy combined with surgery. 相似文献
Objective. We evaluated chemotherapy in a patient with advanced extramammary Paget's disease of the male genitalia unassociated with an underlying malignancy.
Methods. In order to treat a patient with extramammary Paget's disease who had multiple metastases, 500 mg/day of 5-fluorouracil (7 days per week) and 5 mg/day of cisplatin (5 days per week) were administrated intravenously for 24 hours and 1 hour, respectively. This protocol was continued for 6 weeks.
Results. A partial response was observed in both primary disease and metastatic disease. The primary tumor resolved almost entirely, leaving only a scar. Computed tomography scan revealed liver metastases that appeared to change into necrotic tissue; the metastases in lymph nodes and adrenal glands were markedly decreased and hardly detectable. In addition, the carcinoembryonic antigen level, a useful tumor marker for extramammary Paget's disease, decreased remarkably. It is suggested that this patient's survival period could have been prolonged. Serious side effects were not observed during this treatment.
Conclusion. In one patient with extramammary Paget's disease and multiple metastases, low-dose FP therapy appeared to be beneficial. This regimen may be effective for extramammary Paget's disease with systemic nodular metastasis as an adjuvant therapy combined with surgery. 相似文献
998.
999.
F.M. Vanhoenacker MD PhD B. Op de Beeck MD A.M. De Schepper MD PhD R. Salgado MD A. Snoeckx MD P.M. Parizel MD PhD 《Seminars in Ultrasound, CT and MRI》2007,28(1):35-51
A wide range of vascular disorders can affect the spleen. Although clinical presentation is often nonspecific, early diagnosis and treatment are mandatory in most conditions. Noninvasive imaging techniques are well suited to meet these objectives. Familiarity with normal macroscopic and microscopic vascular anatomy is a prerequisite to understand the pathophysiology of vascular disorders of the spleen. This article deals with diseases of the splenic vasculature (aneurysms, arteriovenous fistula, splenic vein thrombosis, collateral circulation in portal hypertension) as well as vascular disorders affecting the splenic parenchyma (splenic infarct, Gamna-Gandy bodies). Primary vascular tumors and tumor-like conditions of the spleen will be discussed very briefly. 相似文献
1000.
Ross BD; Jacobson S; Villamil F; Korula J; Kreis R; Ernst T; Shonk T; Moats RA 《Radiology》1994,193(2):457